Overview

Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
We aim to compare the sensitivity of mammography to the sensitivity of Molecular Breast Imaging (a new gamma-camera based breast imaging technology) in women with dense breast tissue who are at increased risk for breast cancer.
Phase:
N/A
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
Susan G. Komen Breast Cancer Foundation
Treatments:
Technetium Tc 99m Sestamibi